Thursday April 17, 12:00 PM - 1:00 PM EDT / 18:00 - 19:00 CEST

Laboratory detection of carbapenem resistant organisms – the emerging role of molecular assaysto define carbapenemase producers

Presented by Prof. Neil Woodford, Head of Antimicrobial Resistance and Healthcare Associated Infections Reference Unit (AMRHAI), Public Health England

Acquired carbapenemases are a public health concern and have been described as the Gram-negative resistance issue for the next 5-10 years. Limiting the impact of carbapenemases requires rapid detection by the clinical laboratory, to identify infected and colonized patients so that infection control practices can be implemented to prevent or minimize onwards transmission. This webinar presentation will review the full range of available laboratory methods for detection of carbapenem resistance and discuss the current and future role for molecular testing in preventing the spread of these deadly organisms.

Co-sponsored by BD Diagnostics and Check-Points.